Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
J Extra Corpor Technol ; 44(2): 66-8, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22893985

ABSTRACT

Angiotensin converting enzyme inhibitors (ACEIs) are widely used in the treatment of hypertension, myocardial infarction, and congestive heart failure. They have a known adverse effect of unresponsiveness to vasoconstrictors resulting in hypotension for the patients undergoing cardiac surgery. We report a case of a 43-year-old female patient with preoperative lisinopril (2.5 mg per day for a week prior to cardiac surgery), who was diagnosed with severe mitral and tricuspid valve regurgitation. She underwent both a mitral and tricuspid valve replacement operation using cardiopulmonary bypass (CPB). To address her ACEI-associated hypotension on cardiopulmonary bypass, bypass flows were as high as cardiac index of greater than 3 (3.1 +/- .2) L/min/m2 to provide sufficient perfusion indicated by cerebral oxymetry monitoring and adequate urine on pump. In addition, due to unresponsiveness to regular concentration of neosynephrine (neo), boluses of higher concentrations up to 320 microg/mL of neo were administered to maintain the perfusion pressure on pump. The patient was weaned from CPB uneventfully and was discharged home on postoperative day 7. Additional therapeutic treatment to ACEI-associated hypotension and unresponsiveness to neo for the patients undergoing cardiac surgery using CPB is reviewed as well in this paper.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/adverse effects , Cardiopulmonary Bypass , Lisinopril/adverse effects , Phenylephrine/administration & dosage , Vasoconstrictor Agents/administration & dosage , Adult , Female , Humans , Hypotension/chemically induced , Mitral Valve Insufficiency/surgery , Tricuspid Valve Insufficiency/surgery
2.
Pacing Clin Electrophysiol ; 33(6): 727-33, 2010 Jun 01.
Article in English | MEDLINE | ID: mdl-20180917

ABSTRACT

BACKGROUND: Evaluation of the need for prophylactic internal cardiac defibrillators among patients with ischemic cardiomyopathies should be deferred until at least 3 months after revascularization procedures to allow adequate time for recovery of ventricular function. METHODS: Among patients with left ventricular systolic dysfunction (LVSD) who undergo coronary artery bypass grafting (CABG), the proportion of patients who are risk stratified postoperatively with reassessment of left ventricular ejection fraction (LVEF) is unknown. RESULTS: One hundred and six patients with LVSD (LVEF < 40%) who underwent CABG during 2004-2006 and survived 3 months post CABG were evaluated. Follow-up was assessed by chart review and telephone contact. LVEF was not reassessed in 24% (25/106) of the population, none of whom underwent internal cardioverter defibrillator (ICD) implantation. Of those with LVEF reassessed, persistent LVSD was present in 20/81 (25%), 12 of whom were referred for prophylactic ICD placement. CONCLUSION: One-fourth of patients with LVSD who undergo CABG do not have LVEF reassessed postoperatively which may lead to underutilization of ICDs.


Subject(s)
Coronary Artery Bypass , Defibrillators, Implantable/statistics & numerical data , Ventricular Dysfunction, Left/therapy , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies , Stroke Volume , Treatment Outcome
3.
J Thorac Cardiovasc Surg ; 139(6): 1511-1518.e4, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19818456

ABSTRACT

OBJECTIVE: We investigated whether use of radial artery versus saphenous vein grafts during coronary artery bypass grafting reoperations is associated with a significant long-term survival benefit. METHODS: We reviewed a series of 347 consecutive coronary artery bypass grafting reoperations (1996-2007; 270 [78%] male patients; age, 65.3 +/- 9.2 years). Internal thoracic artery grafts were used in 248 (71%) patients at the time of the first coronary artery bypass grafting operation and in 154 (44%) patients at reoperation. Patients were grouped based on whether a functional radial artery graft was present after coronary artery bypass grafting reoperation (radial artery cohort, n = 203 [59%]) or not (saphenous vein cohort, n = 144 [41%]). Median time to reoperation was similar for the radial artery (10.3 years) and saphenous vein (10.1 years) cohorts (P = .55). Angiographic data were used to ascertain the number and type of grafts that remained functional from initial coronary artery bypass grafting. Survival data (< or = 12 years) were time segmented based on multiphase hazard modeling at 90 days, and late survival was then analyzed by using proportional hazard Cox regression, with risk adjustment based on a radial artery-use propensity score computed from 48 covariates, including time to reoperation, month of surgical intervention, and total arterial and vein grafts after reoperation. Propensity-matched and propensity quintile comparisons were also done. RESULTS: Follow-up was similar for the radial artery versus saphenous vein cohorts (5.7 +/- 3.4 vs 5.8 +/- 4.0 years, P = .86), and 112 (50 in the radial artery and 62 in the saphenous vein cohorts) deaths were documented. Early mortality (< or = 90 days) did not differ for the radial artery (7.4%) and saphenous vein (12.5%) cohorts (P = .14). Unadjusted late outcomes were superior for the radial artery versus saphenous vein cohorts, with survival of 97.3% versus 92.9%, 84.9% versus 77.2%, and 74.1% versus 60.3% at 1, 5, and 10 years, respectively. Propensity-adjusted radial artery survival was superior, with a hazard ratio of 0.58 (P = .04), and this result was confirmed in a propensity-matched comparison. CONCLUSIONS: We conclude that the use of radial artery as opposed to saphenous vein grafting for reoperative coronary artery bypass grafting, either with or without concomitant internal thoracic artery grafts, is associated with a substantial improvement in late survival. This benefit is likely derived from the increased overall number of arterial grafts.


Subject(s)
Coronary Artery Bypass , Coronary Artery Disease/mortality , Coronary Artery Disease/surgery , Radial Artery/transplantation , Saphenous Vein/transplantation , Aged , Female , Humans , Male , Reoperation , Retrospective Studies , Survival Rate , Time Factors , Treatment Outcome
4.
Interact Cardiovasc Thorac Surg ; 9(5): 793-6, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19661119

ABSTRACT

Ischemic preconditioning has been shown to attenuate the rise in creatine kinase-myocardial band levels that occur with coronary artery bypass surgery (CABG). Recently, concerns have been raised that some sulfonylureas particularly glibenclamide may block ischemic preconditioning. The purpose of this study was to determine the effect of various diabetic medicines on creatine kinase-myocardial band levels after CABG. In this retrospective study of 799 patients undergoing CABG, patients continued their routine diabetic medicines up to the day of surgery. Intra-operatively and postoperatively, tight glycemic control was maintained with an insulin infusion. Anesthesia was maintained with isoflurane supplemented by fentanyl. Creatine kinase-myocardial band levels were determined the day after surgery at 05:00 h and the mean levels compared between diabetics and non-diabetics and further compared by type of diabetic medicine. After univariable comparisons, linear regression was used to determine the statistically significant predictors of creatine kinase-myocardial band levels. After correction for other factors, none of the diabetic medicines was a statistically significant predictor of creatine kinase-myocardial band levels. We found that the use of glibenclamide or other diabetic medications had no effect on creatine kinase-myocardial band levels the morning after patients underwent CABG.


Subject(s)
Coronary Artery Bypass , Coronary Artery Disease/surgery , Creatine Kinase, MB Form/blood , Diabetes Mellitus/drug therapy , Hypoglycemic Agents/therapeutic use , Ischemic Preconditioning , Myocardial Infarction/prevention & control , Aged , Biomarkers/blood , Blood Glucose/drug effects , Coronary Artery Bypass/adverse effects , Coronary Artery Bypass/mortality , Coronary Artery Disease/blood , Coronary Artery Disease/mortality , Diabetes Mellitus/blood , Diabetes Mellitus/mortality , Female , Glycated Hemoglobin/metabolism , Humans , Hypoglycemic Agents/adverse effects , Linear Models , Male , Middle Aged , Myocardial Infarction/blood , Myocardial Infarction/etiology , Myocardial Infarction/mortality , Retrospective Studies , Risk Assessment , Time Factors , Treatment Outcome
5.
Ann Thorac Surg ; 88(1): 31-9, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19559184

ABSTRACT

BACKGROUND: Increasing the number of arterial grafts for coronary artery bypass grafting (CABG) has been linked to improved late survival. Currently, it is not known if these long-term benefits are also true when sequential radial artery (RA) grafts are the primary means to maximizing arterial revascularization. METHODS: We compared late survival of 532 consecutive patients receiving sequential RA grafts (sequential RA group: 438 men; 462 with three-vessel disease) with that of a 4,131 contemporaneous internal thoracic artery (ITA) with saphenous vein (SV) multivessel CABG cohort (conventional group). Graft failure rates were determined from symptom-driven repeat angiography films in 122 sequential RA patients performed 2 to 4,317 days after surgery. Median survival sequential RA follow-up was 5.3 years (range, 0.5 to 12.3). RESULTS: The sequential RA patients received a total of 1,181 RA grafts (538 sequential [30 triple] and 75 single) along with 636 SV and 533 ITA. Overall RA graft failure (80 of 272; 29%) was intermediate to that for ITA (7 of 121; 5.8%; p < 0.001) and vein (54 of 133, 41.6%; p = 0.032) grafts. Sequential versus nonsequential RA failure did not differ (77 of 252 [31%] versus 3 of 20 [15%]; p = 0.202), while failure of the proximal (36 of 123; 29%) and distal (40 of 129; 31%) components of sequential RA grafts were essentially identical. A total of 69 deaths (6 operative; 1.1%) have occurred in the sequential RA cohort. Unadjusted 10-year sequential RA cohort survival was 76.2% overall, and 79.0% for the 454 primary isolated CABG subgroup. The risk-adjusted 10-year survival using a logit propensity score was substantially better for the sequential RA cohort versus the conventional CABG cohort (risk ratio [95% confidence interval] 0.61 [0.44 to 0.85]; p = 0.003). CONCLUSIONS: Sequential RA grafting is a safe method for maximizing arterial revascularization and is associated with excellent 10-year survival that seems to be superior to conventional or ITA/SV CABG results. Also, the similar proximal and distal sequential RA patency mitigates concerns of a clinically significant effect of increased vasoreactivity of distal segments of RA conduits.


Subject(s)
Coronary Angiography/methods , Coronary Artery Bypass/methods , Coronary Restenosis/diagnostic imaging , Coronary Stenosis/mortality , Coronary Stenosis/surgery , Radial Artery/transplantation , Aged , Cohort Studies , Confidence Intervals , Coronary Artery Bypass/adverse effects , Coronary Restenosis/mortality , Coronary Stenosis/diagnostic imaging , Female , Follow-Up Studies , Graft Rejection , Graft Survival , Humans , Internal Mammary-Coronary Artery Anastomosis , Kaplan-Meier Estimate , Male , Mammary Arteries/transplantation , Middle Aged , Multivariate Analysis , Predictive Value of Tests , Proportional Hazards Models , Retrospective Studies , Risk Assessment , Saphenous Vein/transplantation , Severity of Illness Index , Survival Analysis , Time Factors , Treatment Outcome , Vascular Patency/physiology
6.
Ann Thorac Surg ; 88(1): 95-100, 100.e1-3, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19559202

ABSTRACT

BACKGROUND: Studies in patients undergoing coronary artery bypass grafting (CABG) have shown an increased long-term mortality rates associated with perioperative blood transfusions. However, some studies in other patient populations have shown no effect on death or even a lowered mortality rate in patients receiving blood transfusions, which suggests that the effects of blood transfusion may be disease-dependent. METHODS: Data of all patients who underwent valve operations with or without associated CABG between October 2, 1991, and November 14, 2007, were obtained from the department's database and analyzed using logistic regression for 30-day and Cox models for long-term mortality to determine the effects of transfusion on death. To control for the potential interaction between transfusion and complications and sicker patients being more likely to receive blood, we separately analyzed the data for the different valve populations and used propensity analysis to control for sicker patients being more likely to receive blood. RESULTS: Of 1823 patients who underwent valve operations, the operation was isolated in 993 and combined with CABG in 830. By 30 days, 125 patients (6.9%) had died, and 717 (39%) were dead at follow-up. After controlling for type of operation and factors that influenced the transfusion decision, transfusion was associated with increased death only in patients who had combined valve and CABG, and not in isolated valve operations. CONCLUSIONS: Transfusion had no effect on the mortality rate after isolated valve operations but was associated with increased mortality when valve operations were combined with CABG.


Subject(s)
Cause of Death , Coronary Artery Bypass/mortality , Erythrocyte Transfusion/mortality , Heart Valve Prosthesis Implantation/mortality , Hospital Mortality/trends , Aged , Aged, 80 and over , Analysis of Variance , Aortic Valve/surgery , Cohort Studies , Combined Modality Therapy , Coronary Artery Bypass/methods , Erythrocyte Transfusion/adverse effects , Female , Follow-Up Studies , Heart Valve Prosthesis Implantation/methods , Humans , Kaplan-Meier Estimate , Logistic Models , Male , Middle Aged , Mitral Valve/surgery , Postoperative Complications/mortality , Predictive Value of Tests , Probability , Proportional Hazards Models , Registries , Retrospective Studies , Risk Assessment , Survival Analysis , Time Factors
7.
Ann Thorac Surg ; 87(1): 19-26.e2, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19101262

ABSTRACT

BACKGROUND: Use of one or more arterial grafts to revascularize two-vessel and three-vessel coronary artery disease has been shown to improve coronary artery bypass graft surgery (CABG) survival. Yet, the presumed long-term survival benefits of all-arterial CABG have not been quantified. METHODS: We compared propensity-adjusted 12-year survival in two contemporaneous multivessel primary CABG cohorts with all patients receiving 2 or more grafts: (1) all-arterial cohort (n = 612; 297 three-vessel disease [49%]); and (2) single internal thoracic artery (ITA) plus saphenous vein (SV) cohort (n = 4,131; 3,187 three-vessel disease [77%]). RESULTS: Early (30-day) deaths were similar for the all-arterial and ITA/SV cohorts (8 [1.30%] versus 69 [1.67%]) whereas late mortality was substantially greater for the ITA/SV cohort (85 [13.9%] versus 1,216 [29.4%]; p < 0.0001). The risk-adjusted 12-year survival was significantly better for all-arterial (with a risk ratio [RR] = 0.60; 95% confidence interval [CI]: 0.48 to 0.75; p < 0.001), but this benefit was true only for three-vessel disease (RR = 0.58; 95% CI: 0.43 to 0.78; p < 0.001) and not for two-vessel disease (RR = 0.97; 95% CI: 0.66 to 1.43; p = 0.89). The all-arterial survival benefit was also true for varying risk subcohorts: no diabetes mellitus (RR = 0.50; 95% CI: 0.37 to 0.69), diabetes mellitus (RR = 0.77; 95% CI: 0.56 to 1.07), ejection fraction 40% or greater (RR = 0.60; 95% CI: 0.45 to 0.78), and ejection fraction less than 40% (RR = 0.62; 95% CI: 0.40 to 0.98). Lastly, the multivariate analysis indicated a strong long-term effect of completeness of revascularization, particularly for all-arterial patients, so that compared with patients with two grafts, survival was significantly better when three grafts (RR = 0.54; 95% CI: 0.33 to 0.87) or four grafts (RR = 0.40; 95% CI: 0.21 to 0.76) were completed. CONCLUSIONS: All-arterial revascularization is associated with significantly better 12-year survival compared with the standard single ITA with saphenous vein CABG operation, in particular for triple-vessel disease patients. The completeness of revascularization of the underlying coronary disease is critical for maximizing the long-term benefits of arterial-only grafting.


Subject(s)
Cause of Death , Coronary Disease/surgery , Internal Mammary-Coronary Artery Anastomosis/mortality , Radial Artery/transplantation , Adult , Age Factors , Aged , Aged, 80 and over , Cohort Studies , Coronary Angiography/methods , Coronary Artery Bypass/methods , Coronary Artery Bypass/mortality , Coronary Disease/diagnostic imaging , Coronary Disease/mortality , Female , Follow-Up Studies , Humans , Internal Mammary-Coronary Artery Anastomosis/methods , Kaplan-Meier Estimate , Male , Middle Aged , Postoperative Complications/mortality , Probability , Proportional Hazards Models , Retrospective Studies , Risk Assessment , Severity of Illness Index , Sex Factors , Statistics, Nonparametric , Treatment Outcome
8.
Cardiovasc Pathol ; 18(3): 178-82, 2009.
Article in English | MEDLINE | ID: mdl-18402828

ABSTRACT

BACKGROUND: Endometrial adenocarcinoma of any histologic type rarely metastasizes to the heart. Only three such metastases to the myocardium and three to the pericardium have been reported antemortem in the literature. The rarity of this metastasis is likely explained by the relative avascularity of the endocardium and velocity of blood. METHODS AND RESULTS: A 62-year-old female was admitted for increasing shortness of breath over the previous month. Her past medical history was significant for a resected Stage IC endometrial adenocarcinoma endometrioid type 15 months prior. The tumor was found to be a poorly differentiated (Grade 3) endometrial adenocarcinoma invading over half the myometrium. The periaortic and pelvic lymph nodes as well as the cervix and pelvic organs were free of tumor. The patient was later treated with adjuvant external beam radiotherapy. An echocardiogram demonstrated a large right ventricular mass. Subsequent endocardial biopsy showed a poorly differentiated, Grade 3, endometrial adenocarcinoma of endometrioid histologic type. The tumor was deemed inoperable given its size and vast involvement of the myocardium so palliative care was provided and the patient expired 17 days later. CONCLUSION: Management of metastatic adenocarcinoma to the heart is not well established due to the rarity of this lesion. Previously reported cases vary in the therapeutic approach as well as the outcome. To this date the best outcome has been a survival of 6 years after treatment of the metastasis with radiotherapy and concurrent cisplatin and pegylated liposomal doxorubicin.


Subject(s)
Adenocarcinoma/secondary , Endometrial Neoplasms/pathology , Heart Neoplasms/secondary , Adenocarcinoma/therapy , Biopsy , Cell Differentiation , Echocardiography , Endometrial Neoplasms/therapy , Fatal Outcome , Female , Heart Neoplasms/therapy , Heart Ventricles/pathology , Humans , Middle Aged , Neoplasm Invasiveness , Neoplasm Staging , Palliative Care , Tomography, X-Ray Computed
9.
J Cardiothorac Surg ; 3: 63, 2008 Nov 24.
Article in English | MEDLINE | ID: mdl-19025628

ABSTRACT

BACKGROUND: Diabetes mellitus has become a major health issue in the United States and contributes to morbidity and mortality from coronary artery disease. Despite lifestyle changes and medications that have been shown to decrease complications and death, many persons have poor glycemic control. The purpose of this study is to determine the prevalence of elevated Hemoglobin A1c levels, a marker of glycemic control in patients presenting for coronary artery bypass surgery, and to determine if risk factors for diabetes mellitus could identify those patients with an elevated hemoglobin A1c. METHODS: All patients undergoing coronary artery bypass surgery had hemoglobin A1c levels determined immediately preoperatively. Proportions were used to describe the number of patients with elevated levels. Linear regression and receiver operator characteristic curves were used to evaluate the accuracy of risk factors to identify patients with elevated levels. RESULTS: 83 of 87 (95%) diabetic patients had elevated A1c levels (>or= 6.0%), with 55 of 87 (63%) having inadequate control - A1c levels >or= 7.0. 93 of 163 (57%) non-diabetic patients had elevated A1c levels (>or= 6.0%), with 19 (12%) having levels >or= 7.0%. Risk factors for diabetes mellitus poorly predicted which patient had elevated A1c levels. CONCLUSION: The prevalence of elevated hemoglobin levels in patients undergoing coronary artery bypass surgery is high and routine measurement should be done to permit institution of lifestyle modifications and medication changes that decrease complications and death from diabetes mellitus.


Subject(s)
Coronary Artery Bypass/adverse effects , Diabetes Complications/blood , Glycated Hemoglobin/analysis , Aged , Diabetes Mellitus/epidemiology , Female , Humans , Male , Prevalence , Retrospective Studies , Risk Factors , United States/epidemiology
10.
J Extra Corpor Technol ; 40(2): 99-108, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18705545

ABSTRACT

A hematocrit (Hct) of less than 25% during cardiopulmonary bypass (CPB) and transfusion of homologous packed red blood cells (PRBC) are each associated with an increased probability of adverse events in cardiac surgery. Although the CPB circuit is a major contributor to hemodilution intravenous (IV) fluid volume may also significantly influence the level of hemodilution. The objective of this study was to explore the influence of asanguinous IV fluid volume on CPB Hct and intraoperative PRBC transfusion. After Institutional Review Board approval, a retrospective chart review of 90 adult patients that had undergone an elective, isolated CABG with CPB was conducted. Regression analysis was used to determine if pre-CPB fluid volume was associated with the lowest CPB Hct and the incidence of an intraoperative PRBC transfusion. In separate multivariate analyses, higher pre-CPB fluid volume was associated with lower minimum CPB Hct (p < .0001), and higher minimum CPB Hct was associated with a decreased probability of PRBC transfusion (p < .0001). Compared to patients that received <1600 mL (n = 55) of pre-CPB fluid, those that received >1600 mL (n = 35) had a decreased mean low CPB Hct (22.4% vs 25.6%, p < .0001), an increased incidence of a CPB Hct <25% (74% vs. 38%, p = .0008) and PRBC transfusion (60% vs. 16%, p < .0001), and increased median PRBC units transfused (2.0 vs 1.0, p = .1446) despite no significant difference in gender, age, patient size, baseline Hct, or CPB prime volume. Patients that received a PRBC transfusion (n = 30) received a significantly higher volume of pre-CPB fluid than nontransfused patients (1800 vs. 1350 mL, p = .0039). These findings suggest that pre-CPB fluid volume can significantly contribute to hemodilutional anemia in cardiac surgery. Optimizing pre-CPB volume may preserve baseline Hct and help limit intraoperative hemodilution.


Subject(s)
Cardiopulmonary Bypass/adverse effects , Coronary Artery Bypass , Hemodilution/adverse effects , Infusions, Intravenous/adverse effects , Aged , Erythrocyte Transfusion , Female , Hematocrit/adverse effects , Humans , Male , Medical Audit , Middle Aged , Retrospective Studies
11.
Eur J Cardiothorac Surg ; 33(5): 914-23, 2008 May.
Article in English | MEDLINE | ID: mdl-18356070

ABSTRACT

OBJECTIVES: The evidence supporting the survival benefit of multiple arterial grafts in the general coronary bypass surgery (CABG) population is compelling. Alternatively, results of studies comparing 2 versus 1 internal thoracic artery (ITA) grafts in diabetics have reported conflicting survival data. The use of radial versus ITA as the second arterial conduit has not been studied. METHODS: We obtained complete death follow-up in 1516 consecutive diabetic [64+/-10 years (mean+/-SD). Insulin/no insulin: There were 540 (36%)/976 (64%)] primary isolated CABG patients all with >or=1 ITA grafts. The series included 626 ITA/radial (41%) and 890 ITA/vein (59%) patients. Using separate radial-use propensity models, we matched one-to-one 475 (76%) ITA/radial to 475 (53%) unique ITA/vein patients; each including 166 insulin and 309 no insulin patients. RESULTS: Unadjusted survival was markedly better for (1) ITA/radial (94.3%, 86.7% and 70.4% at 1, 5 and 10 years, respectively) versus ITA/vein (91.8%, 74.5% and 53.8%; p<0.0001) and (2) for no insulin (94.2%, 82.8% and 65.5%) versus insulin (90.4%, 73.1% and 49.2%; p<0.0001). In matched patients, 11-year Kaplan-Meier analysis showed essentially identical ITA/radial and ITA/vein survival for all diabetics combined (p=0.53; log rank) and for the no insulin (p=0.76) cohort. Lastly, a trend for better ITA/radial survival in insulin dependent diabetics after the second postoperative year did not reach significance (p=0.13). CONCLUSIONS: Using radial as a second arterial conduit as opposed to vein grafting did not confer a survival benefit in diabetics. This unexpected result is perhaps related to relatively diminished radial graft patency and/or the augmented radial vasoreactivity characteristic of diabetics. These findings indicate that the radial survival advantage demonstrated in the general CABG population lies primarily in non-diabetics in whom this advantage may be underestimated.


Subject(s)
Coronary Artery Bypass/methods , Coronary Artery Disease/surgery , Diabetes Complications/surgery , Radial Artery/transplantation , Aged , Coronary Artery Disease/complications , Coronary Artery Disease/mortality , Coronary Vessels/surgery , Diabetes Complications/mortality , Diabetes Mellitus, Type 1/mortality , Diabetes Mellitus, Type 1/surgery , Diabetes Mellitus, Type 2/mortality , Diabetes Mellitus, Type 2/surgery , Female , Follow-Up Studies , Humans , Kaplan-Meier Estimate , Male , Mammary Arteries/transplantation , Middle Aged , Proportional Hazards Models , Retrospective Studies , Treatment Outcome , Vascular Patency
12.
J Cardiothorac Vasc Anesth ; 21(6): 820-6, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18068059

ABSTRACT

OBJECTIVE: This study was designed to determine the effect of ketorolac on mortality after cardiac surgery. DESIGN: A retrospective multivariable analysis with propensity matching and propensity scoring. SETTING: A tertiary care university-affiliated medical center. PARTICIPANT: Eleven hundred eighty-six patients undergoing isolated coronary artery bypass surgery. MAIN RESULTS: Between January 1, 2002, and November 1, 2004, 168 patients undergoing isolated coronary artery bypass surgery received ketorolac, whereas 1,018 patients did not. There were 2 deaths (1%) in the ketorolac group compared with 104 (10%) in the nonketorolac group (p < 0.001). Within 90 days of surgery, there was 1 death (1%) in the ketorolac group compared with 51 (5%) in the nonketorolac group (p = 0.01). By Cox modeling, ketorolac use was associated with a 7-fold lower risk of death (p = 0.02). In the patients who survived at least 90 days, there was 1 death (1%) in the ketorolac group compared with 53 (5%) in the nonketorolac group (p = 0.01). By Cox modeling, ketorolac use was associated with a 2.4-fold lower risk of death (p = 0.03) in the late hazard period. In the propensity-matched groups, Kaplan-Meier survival was better in patients who received ketorolac (p = 0.02). CONCLUSION: The use of ketorolac was associated with a statistically significant decrease in mortality at follow-up.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Aspirin , Coronary Artery Bypass/mortality , Ketorolac/administration & dosage , Pain, Postoperative/drug therapy , Administration, Oral , Aged , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/administration & dosage , Aspirin/adverse effects , Combined Modality Therapy , Female , Humans , Kaplan-Meier Estimate , Ketorolac/adverse effects , Male , Middle Aged , Multivariate Analysis , Retrospective Studies , Survival Rate , Time Factors , Treatment Outcome
13.
Ann Thorac Surg ; 84(1): 25-31, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17588376

ABSTRACT

BACKGROUND: Coronary artery bypass grafting with concomitant coronary endarterectomy (CABG/CE) is used in patients with severe coronary atherosclerosis to revascularize otherwise ungraftable targets. This study investigates the efficacy of arterial versus vein grafting for CABG/CE surgery. METHODS: We reviewed our experience in 288 CABG/CE patients (63 +/- 10 years, 207 men). A total of 1,056 grafts (275 internal thoracic artery [ITA] [26%]; 221 radial [21%], 560 vein [53%]) were constructed including 325 (31%) placed to CE targets. RESULTS: Eighteen of 288 patients died in-hospital (6.3%). Unadjusted one-year and five-year survival for the 270 discharged patients was 95.2% and 83.0%, respectively. Survival (0 to 7 years) was significantly better for patients with radial (n = 154) versus no-radial (n = 134) artery grafting (p = 0.021). Multivariate Cox regression analysis associated increased number of arterial grafts (hazard ratio [HR] = 0.64 [0.44 to 0.92]; HR [95% confidence interval]) to improved survival, while RCA endarterectomy (HR = 1.8 1.0 3.3; p = 0.054) was associated with worse survival. Repeat angiography (495 days [median]) in 68 patients encompassed 78 CE (38 vein, 24 ITA, and 16 radial) and 162 non-CE (84 vein, 40 ITA, and 38 radial) grafts. Graft failure was similar (p = 0.37) for radial (10 of 54 [19%]) and ITA (7 of 64 [11%]), and worst for vein (50 of 122 [41%]; p < 0.001). For CE targets, graft failure was worse for vein (55% vs 35%; p = 0.05) and unchanged for arterial (13% vs 15%; p = 0.88) grafts. CONCLUSIONS: Combined CABG/CE is associated with good long-term outcomes. Increased arterial grafting achieved by radial artery utilization confers a survival benefit in this high-risk population. The latter is probably derived from superior radial versus vein graft patency.


Subject(s)
Coronary Artery Bypass/mortality , Coronary Artery Disease/surgery , Endarterectomy/methods , Vascular Patency , Aged , Coronary Artery Bypass/methods , Female , Graft Survival , Humans , Internal Mammary-Coronary Artery Anastomosis , Male , Middle Aged , Multivariate Analysis , Radial Artery/transplantation , Treatment Outcome , Veins/transplantation
16.
Circulation ; 112(21): 3247-55, 2005 Nov 22.
Article in English | MEDLINE | ID: mdl-16286585

ABSTRACT

BACKGROUND: New-onset postoperative atrial fibrillation (AF) is a common complication of cardiac surgery that has substantial effects on outcomes. In the general (nonsurgical) adult population, AF has been linked to increasing obesity, which correlates with left atrial enlargement. It is not known whether postoperative AF is similarly linked to obesity. METHODS AND RESULTS: This was a retrospective analysis of the incidence of AF in terms of body mass index (BMI). A total of 8051 consecutive cardiac surgery patients (1994 to 2004; mean age 64 [SD 11] years; 5372 men [67%]) who were free of any history of preoperative AF or flutter were included in the analysis. This series included 3164 obese patients (39%; median age 62 years) and 4887 nonobese patients (61%; median age 66 years), who were further divided on the basis of BMI (kg/m2) into 6 groups: BMI <22 kg/m2, 22< or =BMI< or =25 kg/m2 (normal), 25 or =30 kg/m2 (overweight), 30 or =35 kg/m2 (obese I), 35 or =40 kg/m2 (obese II), and BMI >40 kg/m2 (obese III). Unadjusted AF incidence was similar in obese and nonobese patients (n=742 [23.5%] versus n=1068 [21.9%], respectively; P=0.099). Covariate-adjusted ORs for AF were systematically greater for larger patients than for patients in the normal group (adjusted OR [95% CI]=1.18 [1.00 to 1.40], 1.36 [1.14 to 1.63], 1.69 [1.35 to 2.11], and 2.39 [1.81 to 3.17] for overweight, obese I, obese II, and obese III, respectively). Other AF predictors included age (adjusted OR=1.52 [95% CI 1.46 to 1.58] per 10 years), mitral valve surgery (adjusted OR=2.42 [95% CI 1.92 to 3.06]), aortic valve surgery (adjusted OR=1.79 [95% CI 1.45 to 2.22]), chronic obstructive pulmonary disease (adjusted OR=1.28 [95% CI 1.12 to 1.46]), male gender (adjusted OR=1.24 [95% CI 1.10 to 1.40]), preoperative beta-blocker use (adjusted OR=1.17 [95% CI 1.05 to 1.32]), vascular disease (adjusted OR=1.18 [95% CI 1.05 to 1.32]), white race (adjusted OR=1.33 [95% CI 1.07 to 1.66]), history of arrhythmia other than AF/flutter (adjusted OR=0.80 [95% CI 0.68 to 0.96]), ejection fraction <40% (adjusted OR=1.16 [95% CI 1.03 to 1.31]), left main disease (adjusted OR=1.15 [95% CI 1.00 to 1.32]), and off-pump surgery (adjusted OR=0.61 [95% CI 0.44 to 0.83]). The obesity-AF association was confirmed in 4 1-to-1 propensity-matched obese versus nonobese comparisons and in 2 separate derivation/validation subcohort analyses. CONCLUSIONS: Obesity is an important determinant of new-onset AF after cardiac surgery. Future postoperative AF risk models should incorporate BMI or obesity levels. Studies examining the efficacy of AF-minimizing prophylactic interventions in high-BMI patients, particularly in the elderly, may be warranted.


Subject(s)
Atrial Fibrillation/epidemiology , Cardiac Surgical Procedures/statistics & numerical data , Obesity/epidemiology , Postoperative Complications/epidemiology , Aged , Atrial Fibrillation/pathology , Body Size , Cardiomegaly/epidemiology , Cardiomegaly/pathology , Cardiopulmonary Bypass/statistics & numerical data , Female , Heart Atria/pathology , Humans , Incidence , Male , Middle Aged , Multivariate Analysis , Postoperative Complications/pathology , Reproducibility of Results , Retrospective Studies , Risk Factors
17.
J Am Coll Cardiol ; 46(8): 1526-35, 2005 Oct 18.
Article in English | MEDLINE | ID: mdl-16226179

ABSTRACT

OBJECTIVES: This study sought to determine whether African-American versus Caucasian race is a determinant of early or late coronary artery bypass surgery (CABG) outcomes. BACKGROUND: African Americans are referred to CABG less frequently than Caucasians and Medicaid coverage is disproportionately common among those who are referred. How these factors affect the relative early and late CABG outcomes in these groups is incompletely elucidated. METHODS: A retrospective cohort comparison of operative and 12-year outcomes for 304 African-American and 6,073 Caucasian consecutive patients who underwent isolated CABG (1991 to 2003) at an urban community hospital was used. Results were further confirmed in propensity-matched subgroups (n = 301 each). RESULTS: African Americans were younger (62 vs. 64 years, median), more were female (46% vs. 30%), more were on Medicaid (29% vs. 6.3%) and had more comorbidities. These differences were eliminated after matching. A total of 161 operative and 1,080 late deaths have been documented. Operative mortality was similar (African American versus Caucasian: 3.0% vs. 2.5%; p = 0.81). Unadjusted Kaplan-Meier survival at 1, 5, and 10 years (93.4%, 80.3%, and 66.1% vs. 94.8%, 86.5%, and 71.7%) was worse in African Americans (hazard ratio [HR] = 1.38; p = 0.004), but similar for matched groups (HR = 1.03; p = 0.97). After risk adjustment, race did not predict operative (odds ratio = 1.17; p = 0.69) or late (HR = 1.15; p = 0.28) mortality. However, Medicaid status (HR = 1.54; p < 0.005) predicted worse survival, which was verified in a case-matched Medicaid (n = 469) versus non-Medicaid analysis. The latter showed that in younger Medicaid patients without companion Medicare coverage, late mortality was nearly doubled (HR = 1.96; p = 0.003) with systematically increasing death hazard after the second year. CONCLUSIONS: African-American race per se is not associated with worse operative or late outcomes underscoring that CABG should be based on clinical characteristics only. Alternatively, Medicaid status, which is more prevalent among African Americans, is associated with worse late survival, especially in non-Medicare patients. Studies are needed to elucidate this late Medicaid-CABG outcome association.


Subject(s)
Coronary Artery Bypass/adverse effects , Coronary Artery Bypass/mortality , Black or African American , Female , Follow-Up Studies , Humans , Male , Middle Aged , Postoperative Complications/epidemiology , Retrospective Studies , Survival Rate , Time Factors , White People
18.
Crit Care Med ; 33(8): 1749-56, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16096452

ABSTRACT

OBJECTIVE: Acute renal injury and failure (ARF) after cardiopulmonary bypass (CPB) has been linked to low on-pump hematocrit (hematocrit). We aimed to 1) elucidate if and how this relation is modulated by the duration of CPB (TCPB) and on-pump packed red blood cell transfusions and 2) to quantify the impact of post-CPB renal injury on operational outcome and resource utilization. DESIGN: Retrospective review. SETTING: A Northwest Ohio community hospital. PATIENTS: Adult coronary artery bypass surgery patients with CPB but no preoperative renal failure. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We quantified post-CPB renal injury via 1) the peak postoperative change in serum creatinine (Cr) level relative to pre-CPB values (%DeltaCr) and 2) ARF, defined as the coincidence of post-CPB Cr > or =2.1 mg/dL and >2 times pre-CPB Cr. The separate effects of lowest hematocrit, intraoperative packed RBC transfusions, and TCPB on %DeltaCr and ARF were derived via multivariate regression, overlapping quintile subgroup analyses, and propensity matching. Lowest hematocrit (22.0% +/- 4.6% sd), TCPB (94 +/- 35 mins), and pre-CPB Cr (1.01 +/- 0.23 mg/dL) varied widely. %DeltaCr varied substantially (24 +/- 57%), and ARF was documented in 89 patients (5.1%). Both %DeltaCr (p < .001) and ARF (p < .001) exhibited sigmoidal dose-dependent associations to lowest hematocrit that were 1) modulated by TCPB such that the renal injury was exacerbated as TCPB increased, 2) worse in patients with relatively elevated pre-CPB Cr (> or =1.2 mg/dL), and 3) worse with intraoperative packed red blood cell transfusions (n = 385; 21.9%), in comparison with patients at similar lowest hematocrit. Operative mortality (p < .01) and hospital stays (p < .001) were increased systematically and significantly as a function of increased post-CPB renal injury. CONCLUSIONS: CPB hemodilution to hematocrit <24% is associated with a systematically increased likelihood of renal injury (including ARF) and consequently worse operative outcomes. This effect is exacerbated when CPB is prolonged with intraoperative packed red blood cell transfusions and in patients with borderline renal function. Our data add to the concerns regarding the safety of currently accepted CPB practice guidelines.


Subject(s)
Acute Kidney Injury/etiology , Cardiopulmonary Bypass/methods , Coronary Artery Bypass , Erythrocyte Transfusion/adverse effects , Hemodilution/adverse effects , Postoperative Complications/etiology , Acute Kidney Injury/epidemiology , Aged , Anemia/complications , Anemia/therapy , Coronary Artery Bypass/mortality , Creatinine/blood , Female , Hematocrit , Humans , Male , Middle Aged , Multivariate Analysis , Ohio/epidemiology , Postoperative Complications/epidemiology , Regression Analysis , Retrospective Studies , Time Factors
20.
Eur J Cardiothorac Surg ; 28(1): 114-9, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15982595

ABSTRACT

OBJECTIVE: The joint European Society of Cardiology and American College of Cardiology consensus statement on myocardial necrosis after revascularization stated that any amount of myocardial necrosis as detected by cardiac enzymes should be labeled a myocardial infarct. However, it also stated that more data collection is necessary to better interpret the elevation of cardiac enzymes after coronary artery bypass grafting. We sought to determine if a single postoperative value of creatine kinase-myocardial band could be used as a risk factor to help predict mortality after coronary artery bypass surgery. METHODS: A retrospective analysis of prospectively collected data on 1161 patients undergoing first-time, isolated coronary artery bypass surgery utilizing normothermic cardiopulmonary bypass was conducted. Creatine kinase-myocardial band was measured the morning after surgery. Binary logistic regression, Cox proportional hazard models, and overlapping quintiles were used to illuminate the association between creatine kinase-myocardial band elevation and mortality after coronary artery bypass surgery. RESULTS: We found a threshold value of creatine kinase-myocardial band, 40 ng/mL, above which elevations were associated with increased death rates. This association held after adjustment for other factors known to contribute to postoperative mortality. However, after 1 year, there was no longer a statistically significant higher mortality associated with elevated creatinine kinase-myocardial band > 40 ng/mL. CONCLUSION: Elevation of creatine kinase-myocardial band the morning after surgery above a threshold 40 ng/mL is associated with an increased risk of mortality.


Subject(s)
Coronary Artery Bypass/mortality , Creatine Kinase/blood , Aged , Biomarkers/blood , Creatine Kinase, MB Form , Epidemiologic Methods , Female , Humans , Isoenzymes/blood , Male , Middle Aged , Myocardial Infarction/diagnosis , Myocardial Infarction/etiology , Myocardial Infarction/mortality , Ohio/epidemiology , Postoperative Period , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...